VitaSpring Biomedical Co. Ltd.
VSBC · OTC
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3,083,365 | $2,883,774 | $1,093,084 | $22,894 |
| - Cash | $30 | $107 | $45 | $0 |
| + Debt | $263 | $464 | $0 | $0 |
| Enterprise Value | $3,083,598 | $2,884,130 | $1,093,039 | $22,894 |
| Revenue | $0 | $5,613 | $248 | $15 |
| % Growth | -100% | 2,161.6% | 1,539.4% | – |
| Gross Profit | -$219 | $2,068 | $112 | $2 |
| % Margin | – | 36.8% | 45.2% | 11.2% |
| EBITDA | -$3,950 | $1,492 | -$424 | -$19 |
| % Margin | – | 26.6% | -170.9% | -125.7% |
| Net Income | -$4,164 | $1,264 | -$425 | $7 |
| % Margin | – | 22.5% | -171.4% | 45.7% |
| EPS Diluted | -0.02 | 0.006 | -0.005 | 0 |
| % Growth | -431.1% | 229.8% | -1,275% | – |
| Operating Cash Flow | -$78 | $85 | -$42 | -$0 |
| Capital Expenditures | -$0 | -$73 | $0 | $0 |
| Free Cash Flow | -$78 | $12 | -$42 | -$0 |